Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro

Journal of Bioscience and Bioengineering

Volumn 109, Issue 6, 2010, Pages 622-628

  Tokumoto, Yasuhito ^a   Ogawa, Shinichiro ^a   Nagamune, Teruyuki ^a   Miyake, Jun ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

embryonic stem cell; induced pluripotent stem cell; multiple sclerosis; oligodendrocyte; regenerative medicine

Indexed keywords

EMBRYONIC STEM CELLS; MULTIPLE SCLEROSIS; OLIGODENDROCYTES; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE;

CELL CULTURE; CELL GROWTH; TISSUE;

STEM CELLS;

TRANSCRIPTION FACTOR NANOG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; EMBRYONIC STEM CELL; FIBROBLAST; IN VITRO STUDY; MOUSE; NONHUMAN; OLIGODENDROGLIA; PLURIPOTENT STEM CELL; PROCESS OPTIMIZATION; PROMOTER REGION;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; FIBROBLASTS; INDUCED PLURIPOTENT STEM CELLS; INTERMEDIATE FILAMENT PROTEINS; MICE; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; TRANSCRIPTION FACTORS;

IPS;

EID: 77952106239     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2009.11.013     Document Type: Article

References (31)

1. Franklin R.J., and ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9 (2008) 839-855
2. McTigue D.M., and Tripathi R.B. The life, death and replacement of oligodendrocytes in the adult CNS. J. Neurochem. 107 (2008) 1-19
3. Sher F., Balasubramaniyan V., Boddeke E., and Copray S. Oligodendrocyte differentiation and implantation: new insights for remyelinating cell therapy. Curr. Opin. Neurol. 21 (2008) 607-614
4. Svendsen C.N., and Smith A.G. New prospects for human stem-cell therapy in the nervous system. Trends Neurosci. 22 (1999) 357-364
5. Brüstle O., Jones K.N., Learish R.D., Karram K., Choudhary K., Wiestler O.D., Duncan I.D., and McKay R.D.G. Embryonic stem cell-derived grail precursors: a source of myelinating transplants. Science 285 (1999) 754-756
6. Liu S., Qu Y., Stewart T.J., Howard M.J., Chakrabortty S., Holekamp T.F., and McDonald J.W. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 6126-6131
7. Billon N., Jolicoeur C., Ying Q.L., Smith A., and Raff M. Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells. J. Cell. Sci. 115 (2002) 3657-3665
8. Weissman I.L. Politic stem cells. Nature 439 (2006) 145-148
9. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
10. Hochedlinger K., and Plath K. Epigenic reprogramming and induced pluripotency. Development 136 (2009) 509-523
11. Takahashi K., Okita K., Nakagawa M., and Yamanaka S. Induction of pluripotent cells from fibroblast cultures. Nat. Protoc. 2 (2007) 3081-3089
12. Okita K., Ichisaka T., and Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 448 (2007) 313-317
13. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., Bernstein B.E., and Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448 (2007) 318-324
14. Hanna J., Wernig M., Markoulaki S., Sun C.W., Meissner A., Cassady J.P., Beard C., Brambrink T., Wu L.C., Townes T.M., and Jaenisch R. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318 (2007) 1920-1923
15. Wernig M., Zhao J.P., Pruszak J., Hedlund E., Fu D., Soldner F., Broccoli V., Constantine-Paton M., Isacson O., and Jaenisch R. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 5856-5861
16. Narazaki G., Uosaki H., Teranishi M., Okita K., Kim B., Matsuoka S., Yamanaka S., and Yamashita J.K. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118 (2008) 498-506
17. Mauritz C., Schwanke K., Reppel M., Neef S., Katsirntaki K., Maier L.S., Nguemo F., Menke S., Haustein M., Hescheler J., Hasenfuss G., and Martin U. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118 (2008) 507-517
18. Dimos J.T., Rodolfa K.T., Niakan K.K., Weisenthal L.M., Matsumoto H., Chung W., Croft F., Saphier G., Leibel R., Goland R., Wichterle H., Henderson C.E., and Eggan K. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321 (2008) 1218-1221
19. Xie C., Huang H., Wei S., Song L.S., Zhang J., Ritchie R.P., Chen L., Zhang M., and Chen Y.E. A comparison of murine smooth muscle cells generated from embryonic versus induced pluripotent stem cells. Stem Cells Dev. 18 (2009) 741-748
20. Kim J.B., Sebastiano V., Wu G., Araúzo-Bravo M.J., Sasse P., Gentile L., Ko K., Ruau D., Ehrich M., van den Boom D., Meyer J., Hübner K., Bernemann C., Ortmeier C., Zenke M., Fleischmann B.K., Zaehres H., and Schöler H.R. Oct4-induced pluripotency in adult neural stem cells. Cell 136 (2009) 411-419
21. Taura D., Noguchi M., Sone M., Hosoda K., Mori E., Okada Y., Takahashi K., Homma K., Oyamada N., Inuzuka M., Sonoyama T., Ebihara K., Tamura N., Itoh H., Suemori H., Nakatsuji N., Okano H., Yamanaka S., and Nakano K. Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells. FEBS Lett. 583 (2009) 1029-1033
22. Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., and Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27 (2009) 275-280
23. Zhang D., Jiang W., Liu M., Sui X., Yin X., Chen S., Shi Y., and Deng H. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res. 19 (2009) 429-438
24. Amabile G., and Meissner A. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol. Med. 15 (2009) 59-68
25. Sommer I., and Schachner M. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nerve system. Dev. Biol. 83 (1981) 311-327
26. Eisenbrath G.S., Walsh F.S., and Nirenberg M. Monoclonal antibody to plasma membrane antigen of neurons. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 4913-4917
27. Tokumoto Y.M., Tang D.G., and Raff M.C. Two molecularly distinct intracellular pathways to oligodendrocyte differentiation: role of a p53 family protein. EMBO J. 20 (2001) 5261-5268
28. Doetschman T.C., Eistetter H., Katz M., Schmidt W., and Kemler R. The in vitro development of blastocyte-derived embryonic stem cell line: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87 (1985) 27-45
29. Vescovi A.L., Reynolds B.A., and Fraser D.D. Weiss, S.: bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells. Neuron 11 (1993) 951-966
30. Bansal R., Stefansson K., and Pfeiffer S.E. Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside. J. Neurochem. 58 (1992) 2221-2229
31. Barres B.A., Hart I.K., Coles H.S., Burne J.F., Voyvodic J.T., Richardson W.D., and Raff M.C. Cell death and control of cell survival in oligodendrocyte lineage. Cell 70 (1992) 31-46